Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies

Kaname Nosaki; Hideo Saka; Yukio Hosomi; Paul Baas; Gilberto de Castro; Martin Reck; Yi‐Long Wu; Julie R. Brahmer; Enriqueta Felip; Takeshi Sawada; Kazuo Noguchi; Shi Rong Han; Bilal Piperdi; Debra Kush; Gilberto Lopes

doi:10.1016/j.lungcan.2019.07.004

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies

著者: Kaname Nosaki, Hideo Saka, Yukio Hosomi, Paul Baas, Gilberto de Castro, Martin Reck, Yi‐Long Wu, Julie R. Brahmer, Enriqueta Felip, Takeshi Sawada, Kazuo Noguchi, Shi Rong Han, Bilal Piperdi, Debra Kush, Gilberto Lopes - Lung Cancer 2019 被引用: 278

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies | Litlas